SUBSCRIBE
SUBSCRIBE

Preclinical

Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Bayer HealthCare Strikes Deal With Mission Bay Incubator Tenant Aronora
February 24, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Despite CEO’s Comments, Experimental Sarepta Drug Protects Lab Monkeys From Ebola
February 11, 2015
 · 
5 min read
BIOCEO15 ContraFect CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015
Drug Development
BIOCEO15: ContraFect CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015
February 9, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Two of Roche’s Experimental Parkinson’s Drugs Caused Lung Toxicity in Monkeys
February 6, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Novartis AG Researchers Claim to Have Discovered “Fountain of Youth” Drug
December 29, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
AstraZeneca PLC To Test Whether It Can Undo Effects Of Its Own Heart Drug Brilinta
November 13, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Omeros Corporation Suspends Enrollment In Huntington’s Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday
October 21, 2014
 · 
2 min read
Ebola Clinical Trials: Big Name Players In The Ebola Race
BioCapital
Ebola Clinical Trials: Big Name Players In The Ebola Race
October 20, 2014
 · 
12 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Drug Development
GlaxoSmithKline’s Experimental Ebola Vaccine Protects Monkeys For 10 Months
September 8, 2014
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Drug Development
Johnson & Johnson Jumps Into The Ebola Race With Collaboration Of Crucell And Bavarian Nordic; Human Trials To Start In Early 2015
September 4, 2014
 · 
2 min read
Load More
PRESS RELEASES
Drug Development
Halberd (HALB) Pursuing a Nasal Spray to Counteract the Effects of Head Trauma
May 2, 2023
 · 
3 min read
Drug Development
Reviva Pharmaceuticals Presented Foundational Preclinical Data on Novel Serotonin-Dopamine Stabilizer Brilaroxazine at the 78th Annual SOBP and Publication in Medical Research Archives
May 1, 2023
 · 
8 min read
Business
2seventy bio and Novo Nordisk Collaboration Delivers Key Proof of Concept Data, Triggering $15 Million Preclinical Milestone in In Vivo Gene Editing Hemophilia A Program
May 1, 2023
 · 
6 min read
Drug Development
Brenus Pharma Unveils Groundbreaking Preclinical Results For STC-10101, a Promising New Drug Candidate Targeting Colorectal Cancer & Solid Tumors
April 27, 2023
 · 
4 min read
Drug Development
Yuyu Pharma, Dry Eye Pipeline Mechanism of Action and Pre-clinical Results Published
April 27, 2023
 · 
2 min read
Drug Development
Arbutus Provides AB-729 Clinical Data and AB-161 Preclinical Data as Oral Presentations at the Global Hepatitis Summit 2023
April 27, 2023
 · 
10 min read
Drug Development
Ashvattha Therapeutics Presents Preclinical Data on anti-VEGF Nanomedicine D-4517.2 at the 2023 ARVO Annual Meeting
April 26, 2023
 · 
5 min read
Drug Development
Uvax Bio Announces Publication of Results from Preclinical Studies of HIV Vaccine Candidates
April 26, 2023
 · 
3 min read
Drug Development
J INTS BIO, AACR 2023 - Presentation of preclinical study results of ‘JIN-A04', an oral target therapy for HER2 exon insertion mutation NSCLC
April 25, 2023
 · 
1 min read
Business
Pan-Biome Pharmaceuticals, a startup focused on age-related diseases and increasing human healthspan, reports positive results in a preclinical trial of colitis
April 25, 2023
 · 
2 min read
Drug Development
BetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, California
April 25, 2023
 · 
4 min read
Drug Development
Valitor Presents Preclinical Data on its Long-acting Anti-VEGF Biologic in Development for Durable Treatment of Wet AMD at the Association for Research in Vision and Ophthalmology Annual Meeting
April 24, 2023
 · 
4 min read
Drug Development
Eyevensys Announces Positive Preclinical Data Demonstrating Superiority of EYS809 over Aflibercept for Wet Age-Related Macular Degeneration (AMD) at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
April 24, 2023
 · 
4 min read
Drug Development
Mydecine Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting MDMA Analogues
April 24, 2023
 · 
6 min read
Drug Development
Dyve Biosciences Presents Preclinical Data from Lead Oncology Drug Candidate, DYV800, at the American Association for Cancer Research 2023 Annual Meeting
April 24, 2023
 · 
2 min read
Drug Development
ProMIS Neurosciences Presents Preclinical Data Highlighting Targeting of Toxic Misfolded Proteins in Alzheimer’s Disease and ALS at American Academy of Neurology Annual Meeting
April 24, 2023
 · 
7 min read
Drug Development
Design Therapeutics to Present Preclinical Data on its GeneTAC™ Small Molecule, DT-168, for the Treatment of Fuchs Endothelial Corneal Dystrophy at ARVO 2023
April 24, 2023
 · 
6 min read
Drug Development
Histogen Announces Online Publication in the Journal of Investigative Dermatology - April 20, 2023
April 20, 2023
 · 
6 min read
Drug Development
Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-in-Class siRNAs Designed with Wave Platform Chemistry
April 20, 2023
 · 
6 min read
Drug Development
OSE Immunotherapeutics Presents Additional Preclinical Updates on CLEC-1, a Novel Myeloid Immune Checkpoint in Immuno-Oncology
April 20, 2023
 · 
8 min read
Load More